{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T12:28:31Z","timestamp":1785241711628,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.actatropica.2020.105714","type":"journal-article","created":{"date-parts":[[2020,9,17]],"date-time":"2020-09-17T12:25:54Z","timestamp":1600345554000},"page":"105714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni"],"prefix":"10.1016","volume":"212","author":[{"given":"Maha M.","family":"Eissa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervat Z.","family":"El-Azzouni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Labiba K.","family":"El-Khordagui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany","family":"Abdel Bary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riham M.","family":"El-Moslemany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara A.","family":"Abdel Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2020.105714_bib0001","doi-asserted-by":"crossref","first-page":"4493","DOI":"10.2147\/IJN.S167285","article-title":"Praziquantel-lipid nanocapsules: an oral nanotherapeutic with potential Schistosoma mansoni tegumental targeting","volume":"13","author":"Amara","year":"2018","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.actatropica.2020.105714_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2020.102051","article-title":"Schistosomiasis and hookworm infection in humans: disease burden, pathobiology and anthelmintic vaccines","volume":"75","author":"Anisuzzaman","year":"2020","journal-title":"Parasitol. Int."},{"issue":"6","key":"10.1016\/j.actatropica.2020.105714_bib0003","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1166\/jbn.2019.2765","article-title":"Size-tailored design of highly monodisperse lipid nanocapsules for drug delivery","volume":"15","author":"Aparicio-Blanco","year":"2019","journal-title":"J. Biomed. Nanotechnol."},{"issue":"1","key":"10.1016\/j.actatropica.2020.105714_bib0004","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4269\/ajtmh.1962.11.25","article-title":"The prophylactic and curative activity of sodium antimony dimercapto succinate (TWSb) in experimental infections with Schistosoma mansoni","volume":"11","author":"Bruce","year":"1962","journal-title":"Am. J. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.actatropica.2020.105714_bib0005","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00227-16","article-title":"Population pharmacokinetics and pharmacodynamics of praziquantel in Ugandan children with intestinal schistosomiasis: higher dosages are required for maximal efficacy","volume":"7","author":"Bustinduy","year":"2016","journal-title":"mBio."},{"key":"10.1016\/j.actatropica.2020.105714_bib0006","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.3389\/fimmu.2018.03042","article-title":"Schistosome egg migration: mechanisms, pathogenesis and host immune responses","volume":"9","author":"Costain","year":"2018","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.actatropica.2020.105714_bib0007","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1128\/AAC.00014-08","article-title":"Pharmacokinetics of miltefosine in old world cutaneous leishmaniasis patients","volume":"52","author":"Dorlo","year":"2008","journal-title":"Antimicrob. Agents. Chemother."},{"issue":"11","key":"10.1016\/j.actatropica.2020.105714_bib0008","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1093\/jac\/dks275","article-title":"Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis","volume":"67","author":"Dorlo","year":"2012","journal-title":"J. Antimicrob. Chemother."},{"issue":"2","key":"10.1016\/j.actatropica.2020.105714_bib0009","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/0035-9203(90)90279-N","article-title":"Praziquantel did not exhibit hepatotoxicity in a study with isolated hepatocytes","volume":"84","author":"Ebeid","year":"1990","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2020.105714_bib0010","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1756-3305-4-73","article-title":"Bioactivity of miltefosine against aquatic stages of Schistosoma mansoni, Schistosoma haematobium and their snail hosts, supported by scanning electron microscopy","volume":"4","author":"Eissa","year":"2011","journal-title":"Parasit. Vectors."},{"issue":"2","key":"10.1016\/j.actatropica.2020.105714_bib0011","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ijpara.2010.09.010","article-title":"Miltefosine, a promising novel agent for Schistosomiasis mansoni","volume":"41","author":"Eissa","year":"2011","journal-title":"Int. J. Parasitol."},{"issue":"11","key":"10.1016\/j.actatropica.2020.105714_bib0012","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141788","article-title":"Miltefosine lipid nanocapsules for single dose oral treatment of Schistosomiasis mansoni: a preclinical study","volume":"10","author":"Eissa","year":"2015","journal-title":"PLoS. One."},{"key":"10.1016\/j.actatropica.2020.105714_bib42","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1186\/s13071-020-04346-1","article-title":"Single oral fixed\u2011dose praziquantel\u2011miltefosine nanocombination for effective control of experimental schistosomiasis mansoni","volume":"13","author":"Eissa","year":"2020","journal-title":"Parasit. Vectors."},{"key":"10.1016\/j.actatropica.2020.105714_bib0014","series-title":"PhD Thesis","article-title":"Development of lipid nanocarriers for the delivery of alkylphosphocholine drugs","author":"El-Moslemany","year":"2015"},{"key":"10.1016\/j.actatropica.2020.105714_bib0015","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.actatropica.2016.03.038","article-title":"Miltefosine lipid nanocapsules: intersection of drug repurposing and nanotechnology for single dose oral treatment of pre-patent schistosomiasis mansoni","volume":"159","author":"El-Moslemany","year":"2016","journal-title":"Acta. Trop."},{"key":"10.1016\/j.actatropica.2020.105714_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118795","article-title":"Triamcinolone acetonide-loaded lipid nanocapsules for ophthalmic applications","volume":"573","author":"Formica","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"9b","key":"10.1016\/j.actatropica.2020.105714_bib0017","first-page":"1137","article-title":"Results of toxicological studies on praziquantel","volume":"34","author":"Frohberg","year":"1984","journal-title":"Arzneimittel-forschung"},{"issue":"1","key":"10.1016\/j.actatropica.2020.105714_bib0018","article-title":"Drug repurposing for schistosomiasis: combinations of drugs or biomolecules","volume":"11","author":"Gouveia","year":"2018","journal-title":"Pharm. (Basel)"},{"issue":"1","key":"10.1016\/j.actatropica.2020.105714_bib0019","article-title":"Morbidity and mortality due to Schistosoma mansoni related periportal fibrosis: could early diagnosis of varices improve the outcome following available treatment modalities in sub Saharan Africa? A scoping review","volume":"5","author":"Gunda","year":"2020","journal-title":"Trop. Med. Infect. Dis."},{"key":"10.1016\/j.actatropica.2020.105714_bib0020","first-page":"1","article-title":"In vivo toxicity evaluation of nanoemulsions for drug delivery","author":"Hort","year":"2019","journal-title":"Drug. Chem. Toxicol."},{"issue":"2","key":"10.1016\/j.actatropica.2020.105714_bib0021","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.pt.2018.10.005","article-title":"Advancing the development of a human schistosomiasis vaccine","volume":"35","author":"Hotez","year":"2019","journal-title":"Trends. Parasitol."},{"issue":"2","key":"10.1016\/j.actatropica.2020.105714_bib0022","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2009.04.026","article-title":"Lipid nanocapsules: a new platform for nanomedicine","volume":"379","author":"Huynh","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2020.105714_bib0023","series-title":"Theory and Practice of Histological Techniques, fifth ed.","first-page":"139","article-title":"Connective tissues and stains","author":"Jones","year":"2002"},{"issue":"1","key":"10.1016\/j.actatropica.2020.105714_bib0024","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s12272-020-01215-4","article-title":"Revolutionizing technologies of nanomicelles for combinatorial anticancer drug delivery","volume":"43","author":"Jo","year":"2020","journal-title":"Arch. Pharm. Res."},{"issue":"5-6","key":"10.1016\/j.actatropica.2020.105714_bib0025","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/1061186X.2018.1547733","article-title":"Drug delivery to tumours using a novel 5-FU derivative encapsulated into lipid nanocapsules","volume":"27","author":"Lollo","year":"2019","journal-title":"J. Drug. Target."},{"key":"10.1016\/j.actatropica.2020.105714_bib43","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41596-018-0101-y","article-title":"Life cycle maintenance and drug-sensitivity assays for early drug discovery in Schistosoma mansoni","volume":"14","author":"Lombardo","year":"2019","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.actatropica.2020.105714_bib0026","first-page":"45","author":"LoVerde","year":"2019"},{"issue":"2","key":"10.1016\/j.actatropica.2020.105714_bib0027","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.pt.2019.11.007","article-title":"Clinical and preclinical imaging of hepatosplenic schistosomiasis","volume":"36","author":"Masi","year":"2020","journal-title":"Trends. Parasitol."},{"issue":"4","key":"10.1016\/j.actatropica.2020.105714_bib0028","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jac\/dkt491","article-title":"The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer)","volume":"69","author":"Olliaro","year":"2014","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.actatropica.2020.105714_bib0029","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.coph.2018.06.004","article-title":"Acting beyond 2020: better characterization of praziquantel and promising antischistosomal leads","volume":"42","author":"Panic","year":"2018","journal-title":"Curr. Opin. Pharmacol."},{"issue":"2","key":"10.1016\/j.actatropica.2020.105714_bib0030","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijpharm.2009.05.069","article-title":"The gastrointestinal stability of lipid nanocapsules","volume":"379","author":"Roger","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actatropica.2020.105714_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2020.105906","article-title":"Searching drugs for Chagas disease, leishmaniasis and schistosomiasis: a brief review","author":"Santos","year":"2020","journal-title":"Int. J. Antimicrob. Agents."},{"issue":"1","key":"10.1016\/j.actatropica.2020.105714_bib0032","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/j.trstmh.2006.02.010","article-title":"Development of miltefosine as an oral treatment for leishmaniasis","volume":"100","author":"Sindermann","year":"2006","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"issue":"4","key":"10.1016\/j.actatropica.2020.105714_bib0033","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1017\/S0031182000086248","article-title":"The infection of laboratory hosts with cercariae of Schistosoma mansoni and the recovery of the adult worms","volume":"55","author":"Smithers","year":"1965","journal-title":"Parasitology"},{"issue":"6","key":"10.1016\/j.actatropica.2020.105714_bib0034","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1080\/00034983.1999.11813462","article-title":"Oral treatment of visceral leishmaniasis with miltefosine","volume":"93","author":"Sundar","year":"1999","journal-title":"Ann. Trop. Med. Parasitol."},{"issue":"1","key":"10.1016\/j.actatropica.2020.105714_bib0035","article-title":"Persistent urogenital schistosomiasis and its associated morbidity in endemic communities within Southern Ghana: suspected praziquantel resistance or reinfection?","volume":"8","author":"Tetteh-Quarcoo","year":"2020","journal-title":"Med. Sci. (Basel)."},{"issue":"6","key":"10.1016\/j.actatropica.2020.105714_bib0036","first-page":"711","article-title":"Host response to eggs of S. mansoni. I. Granuloma formation in the unsensitized laboratory mouse","volume":"41","author":"von","year":"1962","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.actatropica.2020.105714_bib0037","doi-asserted-by":"crossref","first-page":"328","DOI":"10.4269\/ajtmh.19-0658","article-title":"Environmental predictors of schistosomiasis persistent hotspots following mass treatment with praziquantel","volume":"102","author":"Walker","year":"2020","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2020.105714_bib0038","first-page":"1","article-title":"Schistosomiasis then and now: what has changed in the last 100 years?","author":"Wilson","year":"2020","journal-title":"Parasitology"},{"issue":"6","key":"10.1016\/j.actatropica.2020.105714_bib0039","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1007\/s00436-011-2670-3","article-title":"New insight into praziquantel against various developmental stages of schistosomes","volume":"109","author":"Wu","year":"2011","journal-title":"Parasitol. Res."},{"issue":"7","key":"10.1016\/j.actatropica.2020.105714_bib0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003893","article-title":"Inhibition of granulomatous inflammation and prophylactic treatment of schistosomiasis with a combination of edelfosine and praziquantel","volume":"9","author":"Yepes","year":"2015","journal-title":"PLoS. Negl. Trop. Dis."},{"issue":"3","key":"10.1016\/j.actatropica.2020.105714_bib0041","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.7150\/thno.38147","article-title":"Nanocarrier-based drug combination therapy for glioblastoma","volume":"10","author":"Zhao","year":"2020","journal-title":"Theranostics"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X20303193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X20303193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:27:00Z","timestamp":1757550420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X20303193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":42,"alternative-id":["S0001706X20303193"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2020.105714","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of prophylactic efficacy and safety of praziquantel-miltefosine nanocombination in experimental Schistosomiasis mansoni","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2020.105714","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105714"}}